Premium
Hypothalamo‐preoptic Histaminergic Projections in Sleep‐Wake Control in the Cat
Author(s) -
Lin J. S.,
Sakai K.,
Jouvet M.
Publication year - 1994
Publication title -
european journal of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.346
H-Index - 206
eISSN - 1460-9568
pISSN - 0953-816X
DOI - 10.1111/j.1460-9568.1994.tb00306.x
Subject(s) - histaminergic , endocrinology , medicine , histamine , preoptic area , wakefulness , agonist , slow wave sleep , mepyramine , hypothalamus , chemistry , antagonist , receptor , neuroscience , psychology , electroencephalography
Cats were chronically implanted with electrodes for polygraphic recordings and cannulae for intracerebral microinjections in order to study the functional role of histaminergic innervation of the preoptic‐anterior hypothalamus in sleep‐wake control. α‐Fluoromethylhistidine (αFMH, 50 μg in 1 μl), a specific inhibitor of the histamine‐synthesizing enzyme, when injected bilaterally into the preoptic area, where numerous histaminergic fibres and terminal‐like structures are present, caused a significant increase in deep slow wave sleep (S2) and paradoxical sleep (PS) and a decrease in wakefulness. In contrast, microinjections of histamine (5 or 30 μg in 1 μl) in the same area dose‐relatedly increased wakefulness and decreased both slow wave sleep and paradoxical sleep. The effects of histamine were reduced by pretreatment with mepyramine (1 mg/kg i. p.), a well known histamine H 1 receptor antagonist, and were mimicked by a local injection of impromidine (1 μg in 1 μl), a potent histamine H 2 receptor agonist. Microinjections of mepyramine alone (120 μg in 1 μl) caused an increase in slow wave sleep. These results suggest that preoptic histaminergic innervation is involved in sleep‐wake control and that the action might be mediated via both H 1 and H 2 receptors.